An underground market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.
Several experts said the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or prison.
Service Reaction and Content Elimination
According to TikTok, the platform has removed problematic content and banned related hashtags and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.
Within moments of joining one community, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Information and Pricing
Within these communities, messages show dark colored parcels with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service stated it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has already encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially significant health risks”.
